CORRECTSEQ Trademark

Trademark Overview


On Monday, January 17, 2022, a trademark application was filed for CORRECTSEQ with the United States Patent and Trademark Office. The USPTO has given the CORRECTSEQ trademark a serial number of 97222592. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Friday, July 19, 2024. This trademark is owned by CorrectSequence Therapeutics Co., Ltd. The CORRECTSEQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system

Biological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes
correctseq

General Information


Serial Number97222592
Word MarkCORRECTSEQ
Filing DateMonday, January 17, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateFriday, July 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Description of MarkThe mark consists of the word CORRECTSEQ in stylized letters in which the top portion of the letter "C" is outlined and the bottom portion is solid black, with Chinese characters below.
NOT AVAILABLEThe non-Latin characters in the mark transliterate to "ZHENG XU SHENGWU" and this means "CORRECT SEQUENCE" in English.
Goods and ServicesPharmaceutical preparations for use in the treatment of diseases caused by point mutations; Drugs being pharmaceutical preparations for medical purposes for the treatment of diseases caused by point mutations; Stimulants for the central nervous system; Vaccines; Preparations of microorganisms for medical or veterinary use; Cultures of microorganisms for medical and veterinary use; Biological tissue cultures for medical purposes; Diagnostic biomarker reagents for medical purposes; Implants comprising living tissues for transplants; Reagents for medical genetic testing; Stem cells for medical purposes; Pharmaceutical preparations acting on the central nervous system
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesBiological research and analysis; Scientific research in the nature of conducting research and clinical trials for others; Genetic testing for scientific research purposes; Biomedical Research Services; Medical Research Services; Development of pharmaceutical preparations and medicines; Drug Research Services being pharmaceutical research; Structural and functional analysis of genomes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCorrectSequence Therapeutics Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 200120
CN

Party NameCorrectSequence Therapeutics Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 200120
CN

Trademark Events


Event DateEvent Description
Saturday, January 22, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, January 20, 2022NEW APPLICATION ENTERED
Friday, January 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 25, 2022ASSIGNED TO EXAMINER
Friday, October 28, 2022NON-FINAL ACTION E-MAILED
Friday, October 28, 2022NON-FINAL ACTION WRITTEN
Friday, October 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 22, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 25, 2024SOU EXTENSION 1 FILED
Thursday, January 25, 2024SOU EXTENSION 1 GRANTED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 19, 2024SOU EXTENSION 2 GRANTED
Friday, July 19, 2024SOU EXTENSION 2 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED